[(2R,3S,4S,5R,6R)-4,5-di(butanoyloxy)-6-(butanoyloxymethyl)-2-[(2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexoxy]tetrahydropyran-3-yl]octanoate

ID: ALA4752006

PubChem CID: 162653139

Max Phase: Preclinical

Molecular Formula: C32H56O15

Molecular Weight: 680.78

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCCCCCC(=O)O[C@@H]1[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)O[C@H](COC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H]1OC(=O)CCC

Standard InChI:  InChI=1S/C32H56O15/c1-5-9-10-11-12-16-26(39)47-31-30(46-25(38)15-8-4)29(45-24(37)14-7-3)22(19-42-23(36)13-6-2)44-32(31)43-18-21(35)28(41)27(40)20(34)17-33/h20-22,27-35,40-41H,5-19H2,1-4H3/t20-,21-,22-,27-,28-,29-,30+,31+,32-/m1/s1

Standard InChI Key:  BHKJHIRDGAGOBO-NLBUCSMPSA-N

Molfile:  

 
     RDKit          2D

 47 47  0  0  0  0  0  0  0  0999 V2000
   18.2332  -14.5499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2332  -15.3790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9494  -15.7874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6655  -15.3790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6655  -14.5499    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.9494  -14.1290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3835  -15.7925    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.9494  -16.6165    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.5151  -15.7925    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.9494  -13.2998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5133  -14.1352    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.6680  -12.8873    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.3844  -16.6175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0993  -17.0293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1002  -17.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8151  -18.2660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8160  -19.0910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8133  -16.6160    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.3861  -18.2675    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.5291  -17.8527    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.5309  -19.5027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5317  -20.3277    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.1019  -19.5042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.3814  -13.3017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0969  -12.8910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3793  -14.1267    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.8103  -13.3053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5124  -13.3102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7975  -12.8985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2264  -12.8970    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.0835  -13.3119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8010  -15.3793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0862  -15.7910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8020  -14.5543    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.3721  -15.3778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2349  -17.0290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2349  -17.8540    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.5203  -16.6165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8059  -17.0290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8059  -17.8540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0914  -18.2665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3770  -17.8540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3770  -17.0290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6625  -16.6165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3730  -14.5528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3686  -12.9001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5258  -12.8945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  4  7  1  1
  3  8  1  1
  2  9  1  1
  6 10  1  1
  1 11  1  6
 10 12  1  0
  7 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 14 18  1  1
 15 19  1  6
 16 20  1  6
 17 21  1  0
 21 22  1  0
 17 23  1  1
 12 24  1  0
 24 25  1  0
 24 26  2  0
 25 27  1  0
 11 28  1  0
 28 29  1  0
 28 30  2  0
 29 31  1  0
  9 32  1  0
 32 33  1  0
 32 34  2  0
 33 35  1  0
  8 36  1  0
 36 37  2  0
 36 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  1  0
 35 45  1  0
 31 46  1  0
 27 47  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4752006

    ---

Associated Targets(non-human)

Schizosaccharomyces pombe (495 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 680.78Molecular Weight (Monoisotopic): 680.3619AlogP: 1.20#Rotatable Bonds: 24
Polar Surface Area: 224.81Molecular Species: NEUTRALHBA: 15HBD: 5
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.59CX Basic pKa: CX LogP: 2.62CX LogD: 2.62
Aromatic Rings: Heavy Atoms: 47QED Weighted: 0.05Np Likeness Score: 1.17

References

1. Tsutsui N,Tanabe G,Ikeda N,Okamura S,Ogawa M,Miyazaki K,Kita A,Sugiura R,Muraoka O.  (2016)  Structure-activity relationship studies on acremomannolipin A, the potent calcium signal modulator with a novel glycolipid structure 4: Role of acyl side chains on d-mannose.,  121  [PMID:27243802] [10.1016/j.ejmech.2016.05.034]

Source